The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Q&A With Paul Hudson of AstraZeneca US: Looking at Diabetes Treatment Beyond Medication
With a complicated condition like diabetes there is more to treatment than finding the right medication for patients. Providing the information they need and direction to help in their daily lives is also a key part of the overall picture.
Does Race or Ethnicity Play a Factor in Type 2 Diabetes Treatment?
June 8th 2015There are a substantial number of factors physicians must take into consideration before starting a patient with type 2 diabetes mellitus on a particular treatment path. According to results from a recent study, the effectiveness of one of the most popular diabetes medications may be dependent on a patient's race or ethnicity.
New Study Results Challenge ADA Standards for Diabetes Treatment
June 8th 2015With multiple factors hurting patients' chances of reaching type 2 diabetes treatment goals – including a lack of timely follow-up appointments and yo-yo blood glucose (A1C) levels – a respected physician recently advised a major shift in treatment, especially early on in the progressive disease.
Q&A With Paul Hudson of AstraZeneca US: ADA Meeting Provides Unique Look at Diabetes Field
With more than 10000 people in Boston for the American Diabetes Association's Scientific Sessions the event provides a chance for some of the top minds in the field to share information.
Diabetes: Promising Link Between Low Vitamin D Levels and Painful Neuropathy
June 8th 2015Pain levels due to diabetic peripheral neuropathy (DPN) may be altered depending on patients' vitamin D levels, a British study. The findings will be presented in a poster session on June 8 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.
Drug Proven to Provide Diabetic Nephropathy Relief
June 6th 2015Oxidative stress plays an important role in the ability for dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, to effectively ease diabetic nephropathy, according to lead author Takashi Hatanaka of Nagoya University. The study will be presented in a poster session on June 6 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.
The Diabetes Pandemic Requires Global Policy Solutions
The global pandemic of diabetes poses a huge public health challenge to every nation. In 2014 more than 380 million people around the world were living with diabetes-8.3% of the adult population. That number is expected to increase to 592 million by 2035.
Increased Risk of Fractures Associated with Subclinical Thyroid Dysfunction
Overt hyperthyroidism is a known risk factor for osteoporosis and fractures. More subtle alterations in thyroid function, such as those that occur in subclinical thyroid dysfunction, may also be associated with increased fracture risk and bone loss, but until recently no clinical trials have adequately explored that issue.
Overuse of Antibiotics in Primary Health Care: Patient Education Crucial, Too
A recent Chinese study of antibiotic use in primary care settings found that up to 93% of respiratory tract infections (RTIs) were treated with antibiotics, with more than 60% reported as inappropriate.
Yet Another Coffee Study Says It's OK to Drink Up
May 29th 2015Danish researchers conducted a meta-analysis that looked at possible associations between coffee intake and obesity, metabolic syndrome, and type 2 diabetes. They reported finding only a low risk of these conditions in coffee drinkers, but no genetic variance to explain the relationships.
Referral to an Endocrinologist: Which Diabetes Patients Benefit the Most?
May 29th 2015With the global boom in type 2 diabetes mellitus, many patients have greatest access to and are well-cared for by their primary care practitioners (PCPs). For those with basic, predictable, garden-variety diabetes, PCPs are perfectly capable of helping them. It's unclear when referral to a specialist for consultation or chronic management is most sensible.